INS and type 2 diabetes mellitus: Despite the recently introduced therapies to manage T2DM, the progressive nature of IR and the inability of β-cells to cope with increased insulin demand still obligate insulin therapy for selected clusters of patients to achieve and maintain adequate glycemic control [6,7,8].